the ceo came in when the stock was already down and he cant control the sp directly. he has taken control of the inventory issue and dealt with it. he has returned the sales and profits back to growth and negotiated well with the FDA compared to say BUBs who are all about the headline but are losing money on every tin they sell. my only interest now is to see more growth and diversification into new products and new markets that add value and generate a high roi.
my hypothesis around elderly nutrition needs to be tested. maybe there is no demand for elderly nutrition- i don't know but i think there is something to it thats worth exploring. to come out with a market leading product they need to put in the work
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.27 |
Change
0.090(1.10%) |
Mkt cap ! $5.987B | |||
| Open | High | Low | Value | Volume |
| $8.18 | $8.33 | $8.16 | $25.84M | 3.148M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3616 | $8.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.27 | 12097 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |